drugset / Trial / NCT07357649
Baricitinib Effects on Procoagulant State in Rheumatoid Arthritis
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This prospective interventional study aims to evaluate the effects of baricitinib on disease activity, lipid profile, atherogenic index, and procoagulant biomarkers including monocyte-derived human tissue factor and D-dimer in patients with rheumatoid arthritis, compared with conventional therapy.
Timeline
- Start
- 2026-01
- Primary completion
- 2026-04
- Completion
- 2026-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Baricitinib | Small molecule | — | Oral |
| Background | Methotrexate | Small molecule | — | — |